Literature DB >> 7247385

Comparative tissue distribution of ceforanide, cefazolin, and cefamandole in rats.

F H Lee, R D Smyth, D R Van Harken.   

Abstract

The comparative tissue distribution of ceforanide, cefazolin, and cefamandole was determined in rats after subcutaneous doses of 100 mg/kg. Ceforanide had the longest plasma half-life, 0.9 h, versus 0.5 h for cefazolin and 0.4 h for cefamandole, and the highest area under the plasma concentration time curve, 324 micrograms x h per ml, versus 184 micrograms x h per ml for cefazolin and 42 micrograms x h per ml for cefamandole. The peak plasma concentrations of ceforanide and cefazolin were 173 and 140 micrograms/ml, respectively, and were threefold higher than that of cefamandole (49 micrograms/ml). Measureable concentrations of the three compounds were found in the liver, kidneys, lungs, submaxillary glands, cervical lymph nodes, bones, heart, abdominal muscles, eyes, and testes, with cefamandole levels being generally lower and more variable. The peak tissue levels of ceforanide and cefazolin were comparable, within the limit of data variation, and were considerably higher than that of cefamandole. The tissue half-lives of these cephalosporins were similar to the respective plasma half-lives.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7247385      PMCID: PMC181490          DOI: 10.1128/AAC.19.4.625

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Clinical pharmacokinetics and safety of high doses of ceforanide (BL-S786R) and cefazolin.

Authors:  R D Smyth; M Pfeffer; A Glick; D R Van Harken; G H Hottendorf
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

2.  Human pharmacokinetics of a new braod-spectrum parenteral cephalosporin antibiotic, ceforanide.

Authors:  M Pfeffer; R C Gaver; D R Van Harken
Journal:  J Pharm Sci       Date:  1980-04       Impact factor: 3.534

3.  Laboratory evaluation of BL-S786, a cephalosporin with broad-spectrum antibacterial activity.

Authors:  F Leitner; M Misiek; T A Pursiano; R E Buck; D R Chisholm; R G DeRegis; Y H Tsai; K E Price
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

4.  Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans.

Authors:  F H Lee; M Pfeffer; D R Van Harken; R D Smyth; G H Hottendorf
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

  4 in total
  2 in total

1.  Cefamandole prophylaxis for cardiovascular surgery: a dosage comparison.

Authors:  B J Zeluff; L O Gentry
Journal:  Tex Heart Inst J       Date:  1987-12

2.  Penetration of ceforanide and cefamandole into the right atrial appendage, pericardial fluid, sternum, and intercostal muscle of patients undergoing open heart surgery.

Authors:  L D Mullany; M A French; C H Nightingale; H B Low; L H Ellison; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.